With over 15 years in the life science industry, Peter strives to provide his clients with the tools they need to make impactful business decisions. He has extensive experience in global pricing and market access dynamics paired with commercialization strategy know-how, both critical areas of understanding to succeed in an ever-evolving and competitive landscape. Peter has led engagements across all major therapeutic areas, with particular emphasis on cardiometabolic disease, immunology, and rare disease. In these spaces, Peter strives to deliver actionable recommendations through a highly collaborative approach with biopharma clients at the brand, franchise, and corporate levels.
Peter has a PhD in Biological Chemistry from MIT with additional training from the Sloan School of Management and graduated magna cum laude with an AB in Chemistry from Occidental College.
Debbi Amanti Belanger
Vini De Nadai